The Direct Index
Report · scanned 2026-10-21

What an AI agent reads on Corion Biotech

An assistant's crawler fetches the page once, without running JavaScript, and reads the text, the structured data and the links. Below is what it gets from corionbiotech.com, taken from the copy the scanner kept.

4,893

characters of text without JavaScript

Organization

structured data for the business

0

of 3 AI crawlers turned away at the edge

Text

The words an agent gets

Title: corion biotech - Cell therapy without cells · language en-US. First 1,800 of 4,893 characters:

corion biotech - Cell therapy without cells Skip to content corion biotechToggle NavigationHomeAbout UsTeamProjectsPreeclampsiaEpithelial CancerNewsContact therapeutic solutions for Women’s health Cell therapy without cells the innovative approach by corion biotech Homeamministratorecorion2024-02-29T19:28:26+01:00 At Corion Biotech we are committed to develop innovative therapeutic solutions for women’s health.The technology is based on a specific cell population derived from the human term placenta known as Placental Mesenchymal Stromal Cells (hPDMSCs). By our proprietary technology, we exploit the unique PDMSCs’s therapeutic abilities to develop our “Cell Therapy without Cells”. The new approach maintains the effectiveness of cell therapy avoiding the risk of direct administration of living allogenic cells to patients. We strongly believe that our approach is the most ethical, safe and effective solution present in the Advanced Therapy Medicinal Products panorama.PREECLAMPSIA PROJECT Preeclampsia affects 3-8% of all pregnancies worldwide, thus being the main cause of fetal-maternal mortality and morbidity. A new drug for Preeclampsia represents an important improvement for the health of millions of mothers and children with a substantial saving for sanitary systems in developed countries. About Preeclampsia ProjectEPITHELIAL CANCER PROJECT Epithelial cancers affecting ovarian and breast tissues represent the first cause of death among all gynecological cancers. Although most patients achieve complete clinical response following standard treatments, a very high percentage of them eventually relapse. Therefore, it is mandatory to develop new therapeutic strategies. About Epithelial Cancer ProjectAbout usCorion Biotech is an innovative startup founded in December 2012 as
Facts

What it can say about the business

A business type in JSON-LDOrganization
Namecorion biotech
Telephoneno
Addressno
Opening hoursno
Menu or price listnothing · 1 prices seen in the text
Cuisine in structured datano
JSON-LD blocks1 (BreadcrumbList, EntryPoint, ImageObject, ListItem, Organization, PropertyValueSpecification)
Actions

The links it would act on

No booking or ordering link found. An agent has nothing to act on.

Everything here comes from fetching the homepage once as a crawler. The report turns it into a score and a list of fixes, with code to paste.